Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease
Following a set dose schedule, like starting low and slowly working up over time, helps people reach the highest dose safely
Clinical trial data show that tirzepatide promotes greater weight loss than semaglutide
Patient assistance programs provide free medication to qualifying low-income uninsured patients, but strict income cutoffs exclude many people who earn too much to qualify yet not enough to afford $900+ monthly medication costs
Our Chicago location makes it easy to get expert care and start your Wegovy weight loss journey today
US$ 28.92
US$ 25.01
US$ 21.10
US$ 23.95
US$ 22.61
US$ 23.66
US$ 21.23
US$ 28.77
US$ 26.89
US$ 22.07
